# The COLchicine and Atrial FIBrillation Trial

Study · id `cardio:ct-nct05928728` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05928728](<https://clinicaltrials.gov/study/NCT05928728>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05928728

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 500 participants.

## Technical summary

Registry record NCT05928728. Randomized; quadruple masking; primary purpose treatment. Start 2023-07-03 (actual); primary completion 2026-06-14 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 500 participants (planned count; ClinicalTrials.gov record NCT05928728, source copy `cardio:ctgov-nct05928728-2024-02-28`, retrieved 2026-10-26)
- Started: 2023-07-03 (actual) (ClinicalTrials.gov record NCT05928728, source copy `cardio:ctgov-nct05928728-2024-02-28`, retrieved 2026-10-26)
- Primary completion: 2026-06-14 (anticipated) (ClinicalTrials.gov record NCT05928728, source copy `cardio:ctgov-nct05928728-2024-02-28`, retrieved 2026-10-26)
- Completion: 2028-11-01 (anticipated) (ClinicalTrials.gov record NCT05928728, source copy `cardio:ctgov-nct05928728-2024-02-28`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT05928728, source copy `cardio:ctgov-nct05928728-2024-02-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05928728-2024-02-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: The COLchicine and Atrial FIBrillation Trial
- Acronym: COLFIB
- Condition: Atrial Fibrillation
- Intervention (Drug): Colchicine
- Intervention (Drug): Placebo
- Lead sponsor: Herlev and Gentofte Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry intervention name matches this record: Colchicine (`cardio:colchicine`)
- Registry lists this organization as the lead sponsor: Herlev and Gentofte Hospital (`cardio:org-herlev-and-gentofte-hospital`)

## Provenance

Content hash: c247e018e18af78e6c3f5463b197c589ea02da92d8d5ffd24eb0b2735f13035c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
